✦ LIBER ✦

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

✍ Scribed by Cesare Gridelli; Ciro Gallo; Anna Ceribelli; Vittorio Gebbia; Teresa Gamucci; Fortunato Ciardiello; Francesco Carozza; Adolfo Favaretto; Bruno Daniele; Domenico Galetta; Santi Barbera; Francesco Rosetti; Antonio Rossi; Paolo Maione; Francesco Cognetti; Antonio Testa; Massimo Di Maio; Alessandro Morabito; Francesco Perrone

Book ID: 117784332
Publisher: The Lancet
Year: 2007
Tongue: English
Weight: 251 KB
Volume: 8
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(07)70146-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-545 Phase II trial of gemcitabine (G)

P-545 Phase II trial of gemcitabine (G) as prolonged infusion in metastatic non small cell lung cancer (NSCLC)

✍ Cartei, Giuseppe; Binato, Samuela; Trestin, AnnaRosa; Ceravolo, Renato; Salmaso, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase II trial of low-dose gemcitabine i

Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer

✍ XIONG, J; FENG, M; QIU, F; XU, J; TAO, Q; ZHANG, L; XIANG, X; ZHONG, L; YU, F; M 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Phase II trial of vinorelbine (VNR) and

Phase II trial of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)

✍ Garcia-Gomez, J; Firvida, J; Garcia-Mata, J; Salgado, M; Calvo, M; Rodriguez, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Gemcitabine versus gemcitabine/carboplat

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

✍ Christer Sederholm 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Phase II trial assessing the combination

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

The MILES-2G phase 2 study of single-age

The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients

✍ Gridelli, Cesare; De Maio, Ermelinda; Barbera, Santi; Sannicolò, Mirella; Piazza 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 219 KB